Cream or tablet? study seeks Women's preference for UTI prevention
NCT ID NCT05723601
First seen Dec 03, 2025 · Last updated May 17, 2026 · Updated 20 times
Summary
This study looks at which form of vaginal estrogen—cream or tablet—post-menopausal women prefer to prevent recurrent urinary tract infections (UTIs). About 21 women who have had multiple UTIs will try both treatments and then choose their favorite. The goal is to find a treatment that women are more likely to stick with, potentially reducing future infections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT URINARY TRACT INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States
Conditions
Explore the condition pages connected to this study.